GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Other Gross PPE

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Other Gross PPE : €0.00 Mil (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Other Gross PPE?

Oxford Cannabinoid Technologies Holdings's Other Gross PPE for the quarter that ended in Oct. 2023 was €0.00 Mil.

Oxford Cannabinoid Technologies Holdings's annual Other Gross PPE declined from May. 2020 (€0.00 Mil) to May. 2021 (€-0.00 Mil) but then increased from May. 2021 (€-0.00 Mil) to Apr. 2023 (€0.00 Mil).


Oxford Cannabinoid Technologies Holdings Other Gross PPE Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Other Gross PPE Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Other Gross PPE
- - - - -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only - 0.03 - - -

Oxford Cannabinoid Technologies Holdings Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines